Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9892 USD | +6.98% |
|
+5.23% | -20.23% |
06-24 | Akebia Therapeutics Names Erik Ostrowski CFO, CBO | MT |
06-24 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.23% | 194M | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024